The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.

The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.

Date of Patent:
Sep. 30, 2014

Filed:

Jun. 19, 2012
Applicants:

Victor J. Torres, New York, NY (US);

Derya Unutmaz, New York, NY (US);

Francis Alonzo, Iii, New York, NY (US);

Inventors:

Victor J. Torres, New York, NY (US);

Derya Unutmaz, New York, NY (US);

Francis Alonzo, III, New York, NY (US);

Assignee:

New York University, New York, NY (US);

Attorney:
Primary Examiner:
Assistant Examiner:
Int. Cl.
CPC ...
A01N 37/18 (2006.01); A61K 38/04 (2006.01); A61P 31/12 (2006.01); A01N 43/42 (2006.01); A61K 31/44 (2006.01); A61K 31/497 (2006.01); A61K 39/395 (2006.01); A61K 38/16 (2006.01);
U.S. Cl.
CPC ...
A61K 38/164 (2013.01);
Abstract

The present invention relates to methods for preventing or treating Human Immunodeficiency Virus (HIV) infection, inflammatory conditions, and graft-versus-host-disease (GVHD) in a subject. Therapeutic compositions of the present invention comprise Leukocidin E (LukE) and/or D proteins or polypeptides. The invention further relates to methods of treatinginfection by administering a composition comprising a CCR5 antagonist or any molecule that blocks LukE/D interaction with CCR5cells in an amount effective to treat theinfection in the subject.


Find Patent Forward Citations

Loading…